What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?
Collins
Peter L
PL
Bukreyev
Alexander
A
Murphy
Brian R
BR
D017934:Coronavirus / Q000235:genetics; D005821:Genetic Techniques; D005822:Genetic Vectors; D008957:Models, Genetic; D009975:Orthomyxoviridae / Q000235:genetics; D017354:Point Mutation; D012328:RNA Viruses / Q000235:genetics* / Q000276:immunology; D011995:Recombination, Genetic; D012449:Safety; D014612:Vaccines / Q000235:genetics*; D014613:Vaccines, Attenuated / Q000235:genetics* / Q000276:immunology; D014614:Vaccines, Synthetic / Q000235:genetics
D014612:Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9788-93
17535926
Virus Res. 1999 Jan;59(1):89-99
10854168
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8197-202
16717197
J Virol. 2006 Nov;80(21):10293-306
17041210
Virus Res. 2008 Feb;131(2):299-303
18006100
BMC Evol Biol. 2005 Oct 06;5:52
16209713
J Virol. 2007 Jan;81(1):150-8
17050610
Proc Biol Sci. 2007 Dec 22;274(1629):3165-74
17956850
J Gen Virol. 2003 Oct;84(Pt 10):2691-2703
13679603
Virology. 2008 Feb 5;371(1):54-60
18028976
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8203-8
16717196
Arch Virol. 1982;72(1-2):1-34
6179501
Curr Opin Mol Ther. 2008 Feb;10(1):46-55
18228181
J Virol. 2003 Oct;77(20):11201-11
14512568
J Virol. 2005 Nov;79(21):13275-84
16227250
J Virol. 2008 Jul;82(13):6782
18544791
Virus Res. 2008 Sep;136(1-2):198-201
18550189
J Virol. 2007 Nov;81(21):11560-8
17715243
Virology. 2008 Aug 1;377(2):255-64
18570964
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17123-7
17942693